MedPath

Effect of Grape seed extract in treatment of fatty liver

Phase 2
Conditions
on Alcoholic Fatty liver Disease.
Fatty (change of) liver, not elsewhere classified
K76.0
Registration Number
IRCT20190731044392N2
Lead Sponsor
Ahvaz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
50
Inclusion Criteria

20-60 years old
Patient with non alcoholic fatty liver disease

Exclusion Criteria

Patients who have diabetes, cardiovascular, kidney and other hepatic diseases
Pregnant or lactating women
Smoking Alcohol consumption
Use of dietary supplements

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath